// App-Quantinova.ai

BSH2020‐PO‐123 : Prevention and management of steroid‐induced hyperglycaemia in outpatient myeloma chemotherapy ‐ a tertiary centre audit and quality improvement project

Researchers

Presenter

  • P. Vassallo

Principal Investigators

  • S. Suntharalingam

  • J. Griffin

Medical Centers

  • Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Oncology (ONC)

Disease

  • Diabetes

  • Prediabetes

  • Multiple Myeloma

Biomarkers

  • Hemoglobin A1c

  • Serpin A6

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Prednisolone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved